Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Weizman

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
CNS Drugs|December 9, 2004
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatmentMichael Poyurovsky, Abraham Weizman, Ronit Weizman
Journal of Psychiatric Research|May 26, 2005
Obsessive-compulsive disorder in elderly schizophrenia patientsMichael Poyurovsky, Josef Bergman, Ronit Weizman
Journal of Clinical Psychopharmacology|March 23, 2002
Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative studyYoram Barak, Eyal Shamir, Ronit Weizman
Psychiatry Research|August 16, 2005
Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up studyMichael Ritsner, Yael Ratner, Anatoly Gibel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Age-related differences in the side effect profile of citalopramYoram Barak, Marnina Swartz, Daniel Levy, et al.
Psychiatry Research|August 7, 2007
Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up studyMichael S Ritsner, Yael Ratner, Anatoly Gibel, et al.
Biological Psychiatry|February 25, 2006
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trialMichael Poyurovsky, Artashes Pashinian, Ronit Weizman, et al.
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Peripheral benzodiazepine receptors reflect trait (early handling) but not state (avoidance learning)Julia Lehmann, Ronit Weizman, Svetlana Leschiner, et al.
International Clinical Psychopharmacology|February 25, 2005
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patientsMichael Poyurovsky, Artashes Pashinian, Aya Levi, et al.
The International Journal of Neuropsychopharmacology|January 27, 2004
Switching elderly chronic psychotic patients to olanzapineYoram Barak, Eyal Shamir, Ilona Mirecki, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
CNS Drugs|December 9, 2004
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatmentMichael Poyurovsky, Abraham Weizman, Ronit Weizman
Journal of Psychiatric Research|May 26, 2005
Obsessive-compulsive disorder in elderly schizophrenia patientsMichael Poyurovsky, Josef Bergman, Ronit Weizman
Journal of Clinical Psychopharmacology|March 23, 2002
Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative studyYoram Barak, Eyal Shamir, Ronit Weizman
Psychiatry Research|August 16, 2005
Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up studyMichael Ritsner, Yael Ratner, Anatoly Gibel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Age-related differences in the side effect profile of citalopramYoram Barak, Marnina Swartz, Daniel Levy, et al.
Psychiatry Research|August 7, 2007
Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up studyMichael S Ritsner, Yael Ratner, Anatoly Gibel, et al.
Biological Psychiatry|February 25, 2006
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trialMichael Poyurovsky, Artashes Pashinian, Ronit Weizman, et al.
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Peripheral benzodiazepine receptors reflect trait (early handling) but not state (avoidance learning)Julia Lehmann, Ronit Weizman, Svetlana Leschiner, et al.
International Clinical Psychopharmacology|February 25, 2005
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patientsMichael Poyurovsky, Artashes Pashinian, Aya Levi, et al.
The International Journal of Neuropsychopharmacology|January 27, 2004
Switching elderly chronic psychotic patients to olanzapineYoram Barak, Eyal Shamir, Ilona Mirecki, et al.
Pageof 4